Phosphorus

Eloxx Pharmaceuticals Reports Third Quarter 2023 Financial and Operating Results and Provides Business Update

Retrieved on: 
Monday, November 13, 2023

WATERTOWN, Mass., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (OTC: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today reported its financial results for the three months ended September 30, 2023, and provided a business update.

Key Points: 
  • WATERTOWN, Mass., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (OTC: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today reported its financial results for the three months ended September 30, 2023, and provided a business update.
  • Data from the Phase 2 study of ELX-02 for Alport Syndrome was included in two presentations at the American Society of Nephrology (ASN) Kidney Week 2023.
  • R&D expenses were $1.3 million for the three months ended September 30, 2023, which included $0.1 million in stock-based compensation.
  • Additionally, we sold shares of common stock through our ATM program during the quarter for gross proceeds of $1.8 million.

New REDUCE-IT® Analyses Show VASCEPA® (icosapent ethyl) Associated with 29 Percent Relative Risk Reduction Compared with Placebo in Prespecified Subgroup of Patients with Metabolic Syndrome, but Without Diabetes at Baseline

Retrieved on: 
Sunday, November 12, 2023

DUBLIN, Ireland and BRIDGEWATER, N.J., Nov. 12, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced results from new REDUCE-IT analyses showing that among statin-treated patients in a prespecified subgroup with history of Metabolic Syndrome, but without diabetes at baseline, the addition of VASCEPA/VAZKEPA (icosapent ethyl) significantly reduced the risk of first and total cardiovascular events. This subgroup was almost exclusively comprised of patients with established cardiovascular disease. The results were presented today at the American Heart Association (AHA) Scientific Sessions 2023, taking place November 11 – 13, 2023 in Philadelphia, PA and simultaneously published in the European Heart Journal Open.

Key Points: 
  • This subgroup was almost exclusively comprised of patients with established cardiovascular disease.
  • The results were presented today at the American Heart Association (AHA) Scientific Sessions 2023, taking place November 11 – 13, 2023 in Philadelphia, PA and simultaneously published in the European Heart Journal Open.
  • The large relative and absolute risk reductions observed supports IPE as an important therapeutic option for patients with metabolic syndrome at high cardiovascular risk, despite lacking robust effects on any metabolic syndrome component.
  • In addition, variation in subjective measures (e.g., waist circumference) may have affected classification of metabolic syndrome.

Seoul Semiconductor Presents New Proposal for SunLike-Enabled Future Smart Farm

Retrieved on: 
Monday, December 18, 2023

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231218199613/en/
    A nutrient analyzer and human cell response tester in Seoul Semiconductor’s bio-laboratory (Photo: Seoul Semiconductor Co., Ltd.)
    Seoul Semiconductor used both regular white LED lights and SunLike natural spectrum LED lights to grow lettuce, a vegetable commonly used as a food ingredient.
  • Seoul Semiconductor has been operating its own plant cultivation and research farm for the past 10 years.
  • This confirms that using lighting closer to natural light in cultivation leads to higher nutrient content in plants.
  • Sunflowers, for which the natural light spectrum was not used, suffered a decrease in bee visits.

Atomic AI Creates First Large Language Model Using Chemical Mapping Data to Optimize RNA Therapeutic Development

Retrieved on: 
Friday, December 15, 2023

Atomic AI, a biotechnology company fusing cutting-edge machine learning with state-of-the-art structural biology to unlock RNA drug discovery, announced that the Company has created the first large language model (LLM) leveraging chemical mapping data.

Key Points: 
  • Atomic AI, a biotechnology company fusing cutting-edge machine learning with state-of-the-art structural biology to unlock RNA drug discovery, announced that the Company has created the first large language model (LLM) leveraging chemical mapping data.
  • In a preprint paper published on bioRxiv, Atomic AI describes its proprietary ATOM-1™ platform component, a foundation model that can accurately predict the structure and function of RNA and help dramatically improve development of RNA therapeutics.
  • Due to this deficiency of “ground-truth” data, it has been challenging to optimize key RNA therapeutic characteristics, including stability, toxicity, and translational efficiency.
  • “By building large datasets based on RNA nucleotide modifications and next-generation sequencing, the team at Atomic AI has created a first-of-its-kind RNA foundation model,” said Stephan Eismann, Ph.D., Founding Scientist and Machine Learning Lead at Atomic AI.

US WorldMeds Announces FDA Approval of IWILFIN™ (eflornithine) to Strengthen Fight Against Aggressive Childhood Cancer

Retrieved on: 
Thursday, December 14, 2023

High-risk neuroblastoma is a challenging disease, with a high mortality rate driven primarily by the risk of relapse after achieving remission.

Key Points: 
  • High-risk neuroblastoma is a challenging disease, with a high mortality rate driven primarily by the risk of relapse after achieving remission.
  • US WorldMeds partnered with the Beat Childhood Cancer Research Consortium at Penn State University, which conducted the preclinical and clinical research to help advance this vital therapy.
  • The Consortium represents a group of over 50 hospitals that offer collaboration through a network of childhood cancer clinical trials.
  • “We are thankful for the dedication of our partners, specifically the Beat Childhood Cancer Research Consortium, who work tirelessly to improve treatment outcomes for pediatric cancer patients.

United States Biochar Market Size, Share & Trends Analysis Report 2023-2030: Pyrolysis, Gasification, Agriculture, Animal Feed, Health & Beauty Products - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 13, 2023

The "U.S. Biochar Market Size, Share & Trends Analysis Report By Technology (Pyrolysis, Gasification), By Application (Agriculture, Animal Feed, Health & Beauty Products), By State, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "U.S. Biochar Market Size, Share & Trends Analysis Report By Technology (Pyrolysis, Gasification), By Application (Agriculture, Animal Feed, Health & Beauty Products), By State, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • Increased population density and human activities such as the rise in infrastructure and industrial development have led to the degradation of soil.
  • Some of the major causes of declined soil quality include deforestation, overgrazing, industrialization, increased agricultural activities, and natural calamities.
  • According to the Earthworm Foundation, in 2021, the United States faced a significant issue with soil erosion, which resulted in an estimated cost of $67.00 billion.

NTT Announces Key Technology Predictions for 2024

Retrieved on: 
Wednesday, December 13, 2023

NTT Ltd. , a leading global IT infrastructure and services company, today announced its key technology predictions for 2024.

Key Points: 
  • NTT Ltd. , a leading global IT infrastructure and services company, today announced its key technology predictions for 2024.
  • While automation lays at the heart of a ‘Dark NOC’, human talent will be key to making it a success.
  • In 2024, more enterprises will work in close partnership with their energy providers to explore more sustainable options.
  • In 2024, vertical specific clouds package software, PaaS, and IaaS layers to deliver industry-centric use cases focused on business outcomes, rather than the technology itself will increase.

Phospholutions Releases Life Cycle Assessment Demonstrating a Nearly 50% Decrease in Phosphorus Fertilizer Carbon Emissions

Retrieved on: 
Wednesday, December 13, 2023

Phospholutions Inc., a pioneer in sustainable fertilizer technology, announces industry-leading carbon reduction in phosphorus fertilizer production following a comprehensive life cycle assessment (LCA) of their groundbreaking RhizoSorb® technology conducted by Sustainable Solutions Corporation.

Key Points: 
  • Phospholutions Inc., a pioneer in sustainable fertilizer technology, announces industry-leading carbon reduction in phosphorus fertilizer production following a comprehensive life cycle assessment (LCA) of their groundbreaking RhizoSorb® technology conducted by Sustainable Solutions Corporation.
  • The LCA findings highlight substantial environmental benefits of RhizoSorb® 8-39-0, the company’s premier fertilizer product.
  • Notably, the reduction in phosphoric acid and ammonia used in fertilizer production with RhizoSorb® technology decreases carbon emissions by nearly 50%.
  • The results from the assessment demonstrate how Phospholutions strengthens global food security and increases farmer profitability by improving fertilizer efficiency and reducing environmental impact.

Moleaer and the City of Lake Elsinore Launch Restoration Plan for Southern California’s Largest Natural Freshwater Lake

Retrieved on: 
Wednesday, December 13, 2023

Moleaer , the pioneer and global leader in nanobubble technology, has launched a project with the City of Lake Elsinore to help restore water quality in the largest natural freshwater lake in Southern California.

Key Points: 
  • Moleaer , the pioneer and global leader in nanobubble technology, has launched a project with the City of Lake Elsinore to help restore water quality in the largest natural freshwater lake in Southern California.
  • View the full release here: https://www.businesswire.com/news/home/20231213479425/en/
    Custom-built nanobubble generator by Los Angeles-based Moleaer was selected by the City of Lake Elsinore to treat its algae-impaired lake with a chemical-free, long-term solution.
  • The nanobubble installation is a critical component of the city's comprehensive Lake Management Plan to renew and restore the ecological balance of Lake Elsinore.
  • The Roadmap to a Renewed and Restored Lake Elsinore initiative includes three applications – peroxide-based algaecide, lanthanum-based water treatment and nanobubble technology – working in concert to eliminate HABs in Southern California’s largest natural freshwater lake.

Introducing LTK Match.AI: Revolutionizing Creator-Brand Collaborations

Retrieved on: 
Tuesday, December 12, 2023

LTK , the platform that powers Creator Commerce™, is introducing its new AI solution, LTK Match.AI.

Key Points: 
  • LTK , the platform that powers Creator Commerce™, is introducing its new AI solution, LTK Match.AI.
  • LTK Match.AI is the personalized matchmaking solution that instantly connects the best creators with brands for maximum performance.
  • At the core of LTK Match.AI is an advanced algorithm, developed in-house by the LTK engineering group.
  • LTK Match.AI condenses what used to take days into mere seconds, offering personalized recommendations for brand-creator collaborations with unparalleled speed and accuracy.